In addition to a pull-forward in demand in Q3, the company benefited from delivering more vehicles than it produced in the ...

After three fantastic years of market gains, many investors are wondering if the rally will come to an end in 2026.

A competitor's setback was Xeris Biopharma 's ( XERS +7.39%) gain on Hump Day. On news that a potential commercial threat to ...

Zooming out, $10 million (or therabouts) isn't a large figure when compared to Ondas's total revenue, which approached $7.2 ...

Join us as we dissect Texas Roadhouse's stock potential and uncover whether this beloved steakhouse chain can continue to ...

Here are three stocks -- including a turnaround, a growth story, and a high-yield play -- that investors will want to dig ...